Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Quality of care for heart patients does not improve in first year of ACO participation
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Routine interventional procedure may present new endometriosis treatment option
Known to be extremely painful at times, many women with endometriosis consider flare-ups of the condition to be debilitating.
Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology
Boston Scientific hopes to officially launch its new IVL system in the first half of 2026.
Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.

Imaging data gathered when patients are first hospitalized can be used to anticipate how their hearts might recover in the weeks and months ahead.

Researchers looked at this question closely, performing a study of their own in addition to a meta-analysis.

The study's authors examined new TAVR programs established from 2012 to 2018.

The group urged all eligible individuals to get vaccinated, noting that vaccine-related side effects have been quite rare.

The study, published in Blood Advances, suggests that a "one size fits all" approach to cardiac care could soon be a thing of the past.

“Our results suggest that BP targets may need to be modified depending on the CV outcome for which the patient is most at risk,” researchers said.

The two treatment options were comparable in many ways—but TAVR was better when it came to limiting hospitalizations for heart failure.

The grant will support the development of smartphone apps, glucose monitoring devices and other technologies that manage diabetes.